Pfizer (PFE) Change in Acquisitions & Divestments (2010 - 2026)

Pfizer (PFE) has reported Change in Acquisitions & Divestments for 17 consecutive years, with $4.6 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments rose 15.7% year-over-year to $4.6 billion; the TTM figure through Mar 2026 stood at $18.6 billion (up 123.94% YoY), while the FY2025 annual figure was $18.0 billion, up 335.05% from the prior year.
• Change in Acquisitions & Divestments declined to $4.6 billion in Q1 2026 per PFE's latest filing, from $4.7 billion in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $21.2 billion in Q4 2023 and bottomed at $658.0 million in Q1 2024.
• Historically, Change in Acquisitions & Divestments has averaged $6.2 billion across 5 years, with a median of $4.7 billion in 2025.
• Annual changes were most pronounced in 2024 — Change in Acquisitions & Divestments tumbled 89.72% — and 2025, when it jumped 520.97%.
• Pfizer's Change in Acquisitions & Divestments stood at $6.7 billion in 2022, then jumped by 215.69% to $21.2 billion in 2023, then tumbled by 87.62% to $2.6 billion in 2024, then surged by 79.58% to $4.7 billion in 2025, then declined by 3.11% to $4.6 billion in 2026.
• Business Quant data shows PFE's Change in Acquisitions & Divestments at $4.6 billion in Q1 2026, $4.7 billion in Q4 2025, and $2.7 billion in Q3 2025.